Related Experiment Videos

Dipyridamole angina: a specific symptom of severe multivessel disease

P Dabizzi1, G Barletta, P Lo Sapio

  • 1Department of Internal Medicine, University of Florence, Italy.

Insights

Dipyridamole-induced ischemia during thallium tests often indicates severe coronary artery disease with collateral circulation. While "dipyridamole angina" is specific, its low sensitivity means it may not appear in all affected patients.

Area of Science:

  • Cardiology
  • Nuclear Cardiology
  • Diagnostic Imaging

Background:

  • Dipyridamole-induced ischemia is linked to angina and ST-segment depression.
  • These symptoms predominantly occur in patients with three-vessel disease, collateral vessels, or both.

Purpose of the Study:

  • To analyze diagnostic relationships between dipyridamole-induced ischemia, angina, and coronary artery disease.
  • To evaluate the significance of dipyridamole angina in conjunction with thallium scintigraphy.

Main Methods:

  • Studied 227 consecutive patients undergoing coronary angiography and dipyridamole-thallium scintigraphy.
  • Correlated findings of perfusion defects, ECG changes, angina, and coronary anatomy.

Main Results:

  • 134 patients had perfusion defects; 46 (34%) showed ST depression, with 12 experiencing 'dipyridamole angina'.
  • These 12 patients had three-vessel disease and collateral circulation.
  • Among patients with positive dipyridamole-thallium tests, 68% had collateral vessels.

Conclusions:

  • Dipyridamole angina during a positive test typically signifies severe coronary stenoses with collateral circulation.
  • Dipyridamole angina demonstrates high specificity but low sensitivity as a diagnostic symptom.
Abstract

Related Concept Videos